195 related articles for article (PubMed ID: 6306923)
21. [Radionuclide diagnosis of retroperitoneal tumors in children].
Shishkina VV; Siniuta BF
Med Radiol (Mosk); 1986 Jun; 31(6):45-9. PubMed ID: 3014258
[TBL] [Abstract][Full Text] [Related]
22. Drug-induced modulation of Tc-99m pyrophosphate tissue distribution: what is involved?
Wahner HW; Dewanjee MK
J Nucl Med; 1981 Jun; 22(6):555-9. PubMed ID: 6262466
[No Abstract] [Full Text] [Related]
23. Cardiac nuclear medicine, part III: acute myocardial infarction and other applications.
Polak JF; Holman BL
Med Instrum; 1981; 15(5):308-11. PubMed ID: 6275246
[No Abstract] [Full Text] [Related]
24. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.
Gertz MA; Brown ML; Hauser MF; Kyle RA
Arch Intern Med; 1987 Jun; 147(6):1039-44. PubMed ID: 3036031
[TBL] [Abstract][Full Text] [Related]
25. [Gluconate scan of the heart in dogs with experimentally induced temporary myocardial ischemia].
Duska F; Novák J; Mazurová Y; Kubícek J; Vizd'a J; Kafka P; Veverková O
Cesk Radiol; 1984 May; 38(3):197-205. PubMed ID: 6744457
[No Abstract] [Full Text] [Related]
26. [Negativity of myocardial scintigraphy with technetium-pyrophosphate in a case of primary cardiac amyloidosis].
Volpi A; Cavalli A; Maggioni AP; Inglese E; Rovelli GE; Neri R; Salvi A
G Ital Cardiol; 1985 Sep; 15(9):925-9. PubMed ID: 3002892
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
[TBL] [Abstract][Full Text] [Related]
28. 99mTc-aminohexylidendiphosphonate and 99mTc-pyrophosphate in the scintigraphic diagnosis of experimental myocardial infarction in dogs.
Duska F; Hadas L; Vizda J; Kafka P; Urbanová E; Palicka V; Mazurová Y; Kuba M; Grossman V
Nuklearmedizin; 1988 Oct; 27(5):226-7. PubMed ID: 2848225
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic considerations in cardiomyopathy: unique scintigraphic pattern of diffuse biventricular technetium-99m-pyrophosphate uptake in amyloid heart disease.
Schiff S; Bateman T; Moffatt R; Davidson R; Berman D
Am Heart J; 1982 Apr; 103(4 Pt 1):562-3. PubMed ID: 6278907
[No Abstract] [Full Text] [Related]
30. [Technetium-99m-pyrophosphate single photon emission computed tomography of the heart in familial amyloid polyneuropathy: comparison with thallium-201 myocardial scintigraphy--a case report].
Imamoto T; Morita K; Onodera S; Tanazawa S; Amoh K; Ishikawa Y; Murakami N; Kawachi H
Kaku Igaku; 1988 Oct; 25(10):1117-23. PubMed ID: 2851670
[No Abstract] [Full Text] [Related]
31. [Uptake of technetium-99m pyrophosphate in cardiac amyloidosis].
Montes J; López L; Martín F; Pinedo JI; Galván R; Ortiz Berrocal J
Rev Esp Cardiol; 1985; 38(4):300. PubMed ID: 2996085
[No Abstract] [Full Text] [Related]
32. Daunorubicin-induced chronic cardiomyopathy--an experimental model system for study of sudden death. A preliminary report.
Rajs J; Isberg B; Paul C; Ahlberg NE
Forensic Sci Int; 1982; 20(3):217-25. PubMed ID: 6292058
[No Abstract] [Full Text] [Related]
33. Technetium-99m pyrophosphate uptake in spontaneously occurring perimyocardial lesions in an inbred strain of DBA/2 mice.
Yoshida A; Matsumori A; Kawai C; Torizuka K
Jpn Circ J; 1982 Nov; 46(11):1197-200. PubMed ID: 6290693
[TBL] [Abstract][Full Text] [Related]
34. Pyrophosphate scan of the temporarily ischemized dog myocardium.
Duska F; Novák J; Vizda J; Kubícek J; Kafka P; Veverková O
Nuklearmedizin; 1981 Dec; 20(6):268-71. PubMed ID: 6276863
[TBL] [Abstract][Full Text] [Related]
35. 99mTc-labelled pyrophosphate myocardial scanning in experiment and in clinical practice.
Vizda J; Duska F; Kubícek J; Kafka P; Novák J; Mazurová Y
Cor Vasa; 1981; 23(6):457-66. PubMed ID: 6277567
[TBL] [Abstract][Full Text] [Related]
36. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
37. Tc-99m pyrophosphate myocardial imaging in perimyocarditis.
Ahmad M; Dubiel JP
J Nucl Med; 1981 May; 22(5):452-4. PubMed ID: 6260911
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic significance of technetium-99m-pyrophosphate, technetium-99m-methylene diphosphonate and gallium-67-citrate scintigraphy in amyloid heart disease--a study with AL amyloidosis and familial amyloid polyneuropathy].
Hongo M; Misawa T; Yamada H; Hirayama J; Okubo S; Fujii T; Kusama S; Ikeda S
Nihon Naika Gakkai Zasshi; 1986 Jan; 75(1):1-8. PubMed ID: 3009667
[No Abstract] [Full Text] [Related]
39. Tc-99m pyrophosphate myocardial imaging in acute myocardial infarction: value and limitations.
Ahmad M
Mo Med; 1981 Sep; 78(9):575-8. PubMed ID: 6273708
[No Abstract] [Full Text] [Related]
40. [Evaluation of an infarct area using technetium-99m pyrophosphate myocardial scintigraphy].
Kondo T; Kiriyama T; Kato Y; Kogame Y; Kaneko K; Sakurai M; Hishida H; Mizuno Y; Takeuchi A; Koga S
J Cardiogr; 1982 Sep; 12(3):699-708. PubMed ID: 6308105
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
